Certified by Founder Lodge
AstronauTx
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $58,462,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 09 ,2023 | Series A | $58,462,000 |
EQT Life Sciences
Dementia Discovery Fund (DDF)
Bristol Myers Squibb
MPM BioImpact
Brandon Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
